Jamjoom Pharma to Hold General Assembly Meeting on February 19 to Discuss Key Policies and Auditor Appointment

The Board of Directors of Jamjoom Pharmaceuticals Factory Company has invited shareholders to participate in the Ordinary General Assembly Meeting (First Meeting), scheduled to be held on February 19, 2025, in Jeddah.

According to the company’s statement on Tadawul, the meeting agenda includes the following items:

1. Voting on the Board of Directors Membership Policy, Standards, and Procedures.
2. Voting on the Company’s Policy on the Rules and Criteria for Competing with the Company.
3. Voting on the appointment of the external auditor, as recommended by the Audit Committee, to review and audit the company’s financial statements for the fiscal year 2025. This also includes auditing the financials for the second and third quarters of 2025 and the first quarter of 2026, along with determining the auditor’s fees.